Surgery Partners (SGRY) EBIAT: 2014-2025
Historic EBIAT for Surgery Partners (SGRY) over the last 12 years, with Q3 2025 value amounting to $25.3 million.
- Surgery Partners' EBIAT rose 17981.07% to $25.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$76.0 million, marking a year-over-year decrease of 21226.0%. This contributed to the annual value of -$168.1 million for FY2024, which is 22424.24% down from last year.
- Per Surgery Partners' latest filing, its EBIAT stood at $25.3 million for Q3 2025, which was up 17981.07% from $44.9 million recorded in Q2 2025.
- Surgery Partners' 5-year EBIAT high stood at $57.7 million for Q2 2023, and its period low was -$108.5 million during Q4 2024.
- Moreover, its 5-year median value for EBIAT was -$100000.0 (2021), whereas its average is $315789.5.
- In the last 5 years, Surgery Partners' EBIAT soared by 2340000.0% in 2022 and then tumbled by 33233.4% in 2024.
- Over the past 5 years, Surgery Partners' EBIAT (Quarter) stood at -$100000.0 in 2021, then soared by 23400.0% to $23.3 million in 2022, then soared by 100.43% to $46.7 million in 2023, then crashed by 332.33% to -$108.5 million in 2024, then skyrocketed by 123.32% to $25.3 million in 2025.
- Its EBIAT stands at $25.3 million for Q3 2025, versus $44.9 million for Q2 2025 and -$37.7 million for Q1 2025.